NCT06419283View on ClinicalTrials.gov

Prospective Study on Safety and Efficacy of Stenting for Chronic Middle Cerebral Artery Occlusion With Limb Dysfunction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

March 1, 2024

Conditions
Chronic Middle Cerebral Artery OcclusionStenting TreatmentModified Rankin ScaleNational Institutes of Health Stroke Scale
Interventions
PROCEDURE

Middle Cerebral Artery Stent Implantation

Middle Cerebral Artery Stent Implantation

DRUG

standard treatment with aspirin.

standard treatment with aspirin.

Trial Locations (1)

516001

Huihong Huang, Huizhou

All Listed Sponsors
lead

Huizhou Municipal Central Hospital

OTHER

NCT06419283 - Prospective Study on Safety and Efficacy of Stenting for Chronic Middle Cerebral Artery Occlusion With Limb Dysfunction | Biotech Hunter | Biotech Hunter